Literature DB >> 20012759

Histamine in pericarditis of children with congenital heart malformations.

D Maslińska1, M Laure-Kamionowska, P Rzodkiewicz, E Lukasik-Wojtecka, D Szukiewicz, M Karolczak, S Masliński.   

Abstract

INTRODUCTION: Congenital heart malformations are risk factors that make children susceptible to infections resulting in inflammation.
MATERIAL AND METHODS: The concentration of histamine as a modulator of inflammation was quantified in pericardial fluid and expression of histamine H(4) receptor (H(4)R) and histamine-releasing factor (HRF) was determined at mRNA and protein levels. Samples of pericardium and pericardial fluid were obtained during cardiac reconstruction surgery in children.
RESULTS: In children with pericarditis, increased levels of histamine were found and expression of H(4)R was localized on mast cells. Expression of HRF was independent of presence or absence of inflammation in pericardium and was localized within stationary epithelial cells.
CONCLUSION: Results indicate that involvement of H4R in pericardial inflammation depends on penetration of mast cells into inflamed tissue, but HRF may not be directly involved in inflammatory reaction of the pericardium.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20012759     DOI: 10.1007/s00011-009-0121-8

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  5 in total

1.  Mast cell distribution, activation, and phenotype in atherosclerotic lesions of human carotid arteries.

Authors:  M Jeziorska; C McCollum; D E Woolley
Journal:  J Pathol       Date:  1997-05       Impact factor: 7.996

2.  A method for the fluorometric assay of histamine in tissues.

Authors:  P A SHORE; A BURKHALTER; V H COHN
Journal:  J Pharmacol Exp Ther       Date:  1959-11       Impact factor: 4.030

3.  Assays for histamine-releasing factors: from identification and cloning to discovery of binding partners.

Authors:  Jacqueline M Langdon; Susan M MacDonald
Journal:  Methods Mol Biol       Date:  2006

4.  Histamine releasing factor (HRF) in pannus of joints affected by rheumatoid arthritis.

Authors:  D Maslinska; J Opertowska; W Chabros; M Maslinska; A Grzybowska-Kowalczyk; A Paradowska; D Szukiewicz; S Maslinski; E Wojtecka-Lukasik
Journal:  Inflamm Res       Date:  2008       Impact factor: 4.575

5.  Inhibition of cytokine gene transcription by the human recombinant histamine-releasing factor in human T lymphocytes.

Authors:  Becky M Vonakis; Rebecca Sora; Jacqueline M Langdon; Vincenzo Casolaro; Susan M MacDonald
Journal:  J Immunol       Date:  2003-10-01       Impact factor: 5.422

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.